B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

Nat Immunol. 2005 Jan;6(1):90-8. doi: 10.1038/ni1144. Epub 2004 Nov 28.

Abstract

B and T lymphocyte attenuator (BTLA) provides an inhibitory signal to B and T cells. Previously, indirect observations suggested that B7x was a ligand for BTLA. Here we show that BTLA does not bind B7x; instead, we identify herpesvirus entry mediator (HVEM) as the unique BTLA ligand. BTLA bound the most membrane-distal cysteine-rich domain of HVEM, distinct from regions where the ligands LIGHT and lymphotoxin-alpha bound HVEM. HVEM induced BTLA tyrosine phosphorylation and association of the tyrosine phosphatase SHP-2 and repressed antigen-driven T cell proliferation, providing an example of reverse signaling to a non-tumor necrosis factor family ligand. The conservation of the BTLA-HVEM interaction between mouse and human suggests that this system is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Line
  • Humans
  • Ligands
  • Lymphocyte Activation*
  • Mice
  • Mice, Inbred BALB C
  • Receptors, Immunologic / metabolism*
  • Receptors, Immunologic / physiology
  • Receptors, Tumor Necrosis Factor / metabolism*
  • Receptors, Tumor Necrosis Factor, Member 14
  • Receptors, Virus / metabolism*
  • Recombinant Fusion Proteins / metabolism
  • Recombinant Fusion Proteins / pharmacology

Substances

  • BTLA protein, mouse
  • Ligands
  • Receptors, Immunologic
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Member 14
  • Receptors, Virus
  • Recombinant Fusion Proteins
  • TNFRSF14 protein, human
  • Tnfrsf14 protein, mouse